Clinical effects of rosuvastatin, a new HMG-CoA reductase inhibitor, in Japanese patients with primary hypercholesterolemia: an early phase II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples